This article is a collaboration between ڴŮ and:
CHICAGO -- Two days after HOPE-3 results were lauded as proof of statins' safety and efficacy, CNN quotes a : "first randomized trial to show risk of cataracts w/statins." ڴŮ asks Deepak Bhatt, Steven Nissen, C. Michael Valentine, and Alfred Bove to put this risk into perspective.